Azole–Flavonoid Hybrids as Emerging Anticancer Agents: A Bioactivity-Focused Review
Pharmaceuticals · 20.02.2026 · 19 (2) · 338
DOI: 10.3390/ph19020338 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 20.02.2026. Verfasst von Mihaela Lipovanu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Grigore T. Popa University of Medicine and Pharmacy Iasi, 16, Universitatii Street, 700115 Iasi, Romania. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite notable progress in drug discovery, cancer treatment remains hindered by limited therapeutic efficacy, poor target specificity, adverse effects, and the development of drug resistance. Molecular hybridization, which integrates two or more bioactive entities into a single molecule, has shown considerable potential to overcome these limitations. Since both azoles and flavonoids have demonstrated anticancer potential, extensive studies have been undertaken to combine the two entities and enhance the bioactivity of the resulting hybrids. In this context, numerous azole–flavonoid hybrids have been synthesized and investigated for their anticancer potential. This review provides an overview of the azole–flavonoid hybrids that are promising candidates for novel anticancer drug development, highlighting their superior antitumor potency compared to reference drugs, multitarget activity, tumor-selective cytotoxicity, efficacy against drug-resistant tumor cells, and structure–activity relationships. The review covers 250 hybrids, primarily triazole–chalcone hybrids but also triazole–flavone, flavanone, flavonol, and isoflavone hybrids, as well as other azole–flavonoid hybrids (imidazole–, pyrazole–, isoxazole–, and thiazole–flavonoid hybrids).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Grigore T. Popa University of Medicine and Pharmacy Iasi, 16, Universitatii Street, 700115 Iasi, Romania.
- Ion Ionescu de la Brad Iasi University of Life Sciences, 3, Mihail Sadoveanu Alley, 700489 Iasi, Romania.
ORCID-Profile: Nina Filip, Cristina Elena Horhogea
Zitieren
APA
Lipovanu, M., Miron, A., Filip, N., Horhogea, C. E., & Aprotosoaie, A. C. (2026). Azole–Flavonoid Hybrids as Emerging Anticancer Agents: A Bioactivity-Focused Review. Pharmaceuticals, 19(2), 338. https://doi.org/10.3390/ph19020338
Vancouver
Lipovanu M, Miron A, Filip N, Horhogea CE, Aprotosoaie AC. Azole–Flavonoid Hybrids as Emerging Anticancer Agents: A Bioactivity-Focused Review. Pharmaceuticals. 2026;19(2):338. doi:10.3390/ph19020338
BibTeX
@article{Lipovanu2026,
author = {Lipovanu, Mihaela and Miron, Anca and Filip, Nina and Horhogea, Cristina Elena and Aprotosoaie, Ana Clara},
title = {Azole–Flavonoid Hybrids as Emerging Anticancer Agents: A Bioactivity-Focused Review},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {2},
pages = {338},
doi = {10.3390/ph19020338}
}
EUVIMED